₹15.02 Crores | Listing at NSE | Thu, Apr 2, 2026 - Thu, Apr 30, 2026
Sunrest Lifescience Limited Rights Issue comprises 0.4291 Cr equity shares aggregating to ₹15.02 Cr, offered at an issue price of ₹35 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Mar 23, 2026, with the Rights Issue being offered in the entitlement ratio of 1 : 1.
The term of payment is defined as following : ₹35 per share payable in full at the time of application.
The Rights Entitlements are expected to be credited to eligible demat accounts on May 4, 2026.
The Rights Issue opens on Apr 2, 2026, and closes on Apr 30, 2026, with renunciation of Rights Entitlements permitted up to Mar 20, 2026.
The deemed date of allotment is May 4, 2026, following which the equity shares are expected to be credited to demat accounts on May 5, 2026 and listed at the NSE on May 6, 2026.
Skyline Financial Services Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Sunrest Lifescience Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Mon, Mar 23, 2026
Entitlement Ratio
1 : 1
Open Date
Thu, Apr 2, 2026
Close Date
Thu, Apr 30, 2026
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 58.65 | 25.16 | 16.71 |
| Total Income | 33.42 | 29.48 | 24.67 |
| Profit After Tax | 2.01 | 0.23 | 2.04 |
| Reserves and Surplus | 12.02 | 9.89 | 0.11 |
| Amount in ₹ Crore | |||
Founded in 2017, Sunrest Lifescience Limited offers a wide range of healthcare and personal care products including capsules, tablets, syrups, ointments, gels, mouthwash, solutions, suspensions, dry powders, and toothpaste. Its portfolio covers drugs like Anti-Bacterial, Anti-Diarrheal, Anti-Fungal, Anti-Malarial, Anti-Diabetic, Dental Care, Anti-Protozoal, Anti-Histamine, Anti-Hypertensive, Cosmetic, Anti-Parasitic, Multivitamins, Multiminerals, Nutraceuticals, and Anti-Inflammatory. The products are manufactured by third-party pharma companies, including Trilend Pharmaceuticals (a Sunrest group company), with 43 manufacturers across Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand, and Madhya Pradesh.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fund Subsidiary for purchasing new plant and machinery at its new production facility. | 6.85 |
| 2 | To Meeting the working capital requirements of the Company. | 5.00 |
| 3 | General Corporate Purposes | 3.17 |
| Total | 15.02 |
[Dilip Davda] SLL is engaged in the business of pharmaceutical products marketing. Its major operation is based on third party supply management. The RI is aggressively priced and has no support from its recent financial data. The company is operating in a highly competitive and fragmented segment. There is no harm in skipping this pricey and dicey RI offer. Read detail review...
Sunrest Lifescience Rights Issue 2026 got subscribed by 0.27 times by the end of the bidding period with total bid quantity received by NSE of 11,47,200 shares. Check Day by Day Subscription Details (Live Status)
| Date | NSE Bid Quantity | Subscription Times |
|---|---|---|
Apr 30 2026 17:00:02 | 11,47,200 | 0.27x |
Sunrest Lifescience Limited
6th Floor 608,
West gate D-Block,
S G Highway, Makarba
Ahmedabad, 380051
Skyline Financial Services Pvt.Ltd.
The Sunrest Lifescience Rights Issue 2026 opens on Thu, Apr 2, 2026, and closes on Thu, Apr 30, 2026.
Sunrest Lifescience Rights Issue 2026 Schedule
| Last Date for credit of Rights Entitlements | Tue, Mar 24, 2026 |
| Last Date for renunciation of Rights Entitlements | Fri, Mar 20, 2026 |
| Issue Opening Date | Thu, Apr 2, 2026 |
| Issue Closing Date | Thu, Apr 30, 2026 |
| Date of Allotment (on or about) | Mon, May 4, 2026 |
| Date of Credit (on or about) | Tue, May 5, 2026 |
| Date of Listing (on or about) | Wed, May 6, 2026 |
You can apply for Sunrest Lifescience Rights Issue 2026 in two ways:
Steps to apply for Sunrest Lifescience Rights Issue 2026 using Net Banking (ASBA)
Steps to apply for Sunrest Lifescience Rights Issue 2026 using Registrar's website (R-WAP)
